Evidence mapPaperPMID 39950476Full record

SynthesisCurrent hypertension reviews2025

Predictive Accuracy of 24-Hour Ambulatory Blood Pressure Monitoring

Hamidreza Soleimani, Negin S H Mohammadi, Sara M Namin, Amir Nasrollahizadeh, Tara Azardar, Kimia Najafi, Mehmet Cilingiroglu, Mushabbar Syed, Mani K Askari, Rahul Gupta and 2 more

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Current hypertension reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hamidreza SoleimaniTehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Negin S H MohammadiTehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-9477-6584
Sara M NaminTehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Amir NasrollahizadehTehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-6328-8468
Tara AzardarTehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Kimia NajafiHakim Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mehmet CilingirogluMD Anderson Cancer Center, University of Texas in Houston, Houston, Texas, USA.
Mushabbar SyedSchool of Medicine, Loyola University Chicago Stritch, Maywood, Illinois, USA.
Mani K AskariDepartment of Medicine, University of Toledo, Ohio, USA.
Rahul GuptaDepartment of Cardiology, Lehigh Valley Health Network, Allentown, PA, USA.
Wilbert S AronowDepartment of Cardiology, New York Medical College and Westchester Medical Center, Valhalla, NY, USA.
Kaveh HosseiniTehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAccording to current clinical practice guidelines, Ambulatory Blood Pressure Measurement (ABPM) is recommended to confirm diagnoses of hypertension. It remains unclear as to which method is superior in predicting mortality outcomes.

methodsProspective observational studies, comparing ABPM with Clinical Blood Pressure Measurements (CBPM), were included with outcomes of the study being all-cause and cardiovascular mortality.

resultsNine studies with a total of 23,140 participants were included. Each 10-mmHg increase in 24-hour mean systolic blood pressure (SBP) was linked to a higher risk of all-cause mortality (HR: 1.13, 95% CI: 1.09-1.18), while Clinic Blood Pressure Measurement (CBPM) was not a significant predictor (HR: 1.02, 95% CI: 0.90-1.13). Nighttime SBP increases of 10 mmHg were associated with a higher all-cause mortality risk than daytime SBP (HR: 1.16, 95% CI: 1.11-1.21

conclusionThe findings of this study support the superiority of ABPM measurements in predicting both all-cause and cardiovascular mortality.

Indexed as

Blood PressureBlood Pressure Monitoring, AmbulatoryCardiovascular DiseasesHypertensionAgedCause of DeathCircadian RhythmFemaleHumansMaleMiddle AgedPredictive Value of TestsPrognosisReproducibility of ResultsRisk AssessmentRisk Factorsambulatory blood pressureantihypertensive drugs.blood pressure monitoringcardiovascular outcomesClinical blood pressurehypertension

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.